Celularity Inc (CELU) Stock Up 9.94% After Earnings

Celularity Inc (CELU) stock experienced a notable upward movement during the trading session following the company's latest earnings release for the second quarter of 2026. Market participants reacted to the financial updates provided by the biotechnology firm.

According to the reported earnings figures for Q2 2026, specific estimates for both earnings per share and revenue were listed as not available, while the overall financial update was delivered to the market.

During the session, Celularity Inc (CELU) shares opened at $0.8058 and fluctuated between an intraday low of $0.78 and a high of $0.9757, eventually closing at $0.8804 compared to the previous close of $0.8008.

Celularity Inc is a biotechnology company classified under pharmaceutical preparations, focusing on the development of placental-derived cell therapies.

The company carries a market capitalization of approximately $25.48M with a trailing twelve-month EPS of -3.59. Its 52-week trading range spans from $0.5601 to $4.0098, alongside a 10-day average trading volume of 0.14694. Financial records for FY2025 show total revenue of $54.2M and a net income of $-57.9M, compared to FY2024 revenue of $22.8M and a net income of $-196.3M.

Broader macroeconomic indicators showed the CBOE Volatility Index (VIX) at 15.45 and the 10-year to 2-year Treasury yield spread at 0.47 during the surrounding period.

Celularity Inc (CELU) continues to be monitored by market observers following the Q2 2026 earnings disclosures and recent trading activity.